Hepatitis B

Hepatitis B is a potentially deadly infection of the liver that kills about 500,000 to 700,000 people each year, mostly in developing countries. The virus is spread perinatally from an infected mother to her infant at birth, from child to child, through unsafe injections and blood transfusions, and through sexual contact. Currently, there is no effective treatment for the disease. Hepatitis B vaccines have been shown to be about 95 percent protective against the disease when used correctly.

Hepatitis B resources on the Vaccine Resource Library were mainly gathered during PATH’s Children’s Vaccine Program, which conducted activities with hepatitis B vaccine from 2001 to 2006 in Vietnam and Cambodia. For additional resources, visit the hepatitis page on the World Health Organization website.

More about hepatitis B | View resources on hepatitis B

Key resources

The Pink Book—Epidemiology and Prevention of Vaccine-Preventable Diseases: Hepatitis B (2012)
A chapter detailing hepatitis B disease and vaccines from the Pink Book, a standard reference on vaccine-preventable diseases.

A web page that provides links to World Health Organization activities, reports, news, and events related to hepatitis, including hepatitis B.

Featured PATH resources

More About Hepatitis B (2012)
A web page that provides links to information about PATH's work on hepatitis B, information about the disease, and a snapshot of the current vaccine landscape.

Using Uniject™ to Increase the Safety and Effectiveness of Hepatitis B Immunization (2002)
A paper that describes the use of an innovative injection device to immunize Indonesian newborns against hepatitis B.

Page last updated: June 2013.